[PDF] Top 20 Autoantibodies to angiotensin converting enzyme 2 in patients with connective tissue diseases

... The exacerbated SLE and progressive necrosis of the fin- gers and toes in Patient 1, a 25-year-old female, were treated with intravenous methylprednisolone at a dose of 500 mg/day for 3 days, followed by 30 mg/day oral ... See full document

... Loss of function mutations in TSC1 and TSC2 have been broadly detected in pulmonary LAM cells: These mutations activate mammalian target of rapamycin (mTOR) protein kinases [29]. Recent studies have re- ported that the ... See full document

... 76 patients with AS, 72 patients with BD, 31 patients with presumed sarcoidosis, and 68 patients with presumed latent TB, 11 patients with presumed latent syphilis, and 22 control ... See full document

... injury patients may develop proteinuria as a result of glomerulosclerosis due to urosepsis, hydronephrosis, vesicoureteric reflux, and renal ...tetraplegic patients, who developed recurrent urine ... See full document

... Kidney diseases and hypertension; ACEI, Angiotensin-Converting Enzyme Inhibitor; ALLHAT, Antihypertensive and Lipid Lowering to prevent Heart Attack Trial; ARB, angiotensin-receptor ... See full document

... of proliferation, migration and hypertrophy of vascular smooth muscle cells, increasing thus its association with CAD and MI risk of occurrence [13]. Many SNPs have been described in ACE gene. Interestingly, the ... See full document

... the patients, includ- ing age, gender, monthly income (,NT$ 19,100, NT$ 19,100–NT$ 41,999, and ...of Diseases, Ninth Revision, Clinical Modification codes and grouped as follows: myocardial infarction, ... See full document

... in patients with established atherosclerotic vascular disease or with diabetes and end-organ damage ...249 patients who under- went aortic surgery and found a relationship between deterioration of postoper- ... See full document

... in patients with ARDS and pa- tients with sepsis [16–19], and it is further underlined by genetic studies of an insertion/deletion (I/D) polymorph- ism within the ACE gene, with the D allele conferring higher ACE ... See full document

... of angiotensin II, which in turn directly in- duces vascular smooth muscle proliferation (34) and myocyte hypertrophy (23, 24), and also induces the release of platelet- derived growth factor (35) and transforming ... See full document

... Epidemiologic studies have previously suggested that premenopausal females have reduced incidence of cardiovascular disease (CVD) when compared to age-matched males, and the incidence and severity of CVD increases ... See full document

... expect patients with sarcopenia to be concentrated in such secondary care clinics, this patient group has mul- tiple exclusion criteria, particularly use of ACEi drugs and the presence of ...eligible ... See full document

... Angiotensin-converting enzyme (ACE) generates the vaso- constrictor angiotensin II, which plays a critical role in maintenance of blood pressure in ...the enzyme is bound to tissues ... See full document

... Therapeutic resistance to antihypertensive agents in the late stage of CKD with diabetes mellitus is consid- ered to be caused some defective mechanisms of vascu- lar homeostasis and impaired nitric oxide production ... See full document

... The concentration of immune modulators in plasma was detected by Milliplex 26-plex (Millipore Corp, St. Charles, Missouri, USA), according to the provided manufacturers’ protocol. This method was applied to analyze a ... See full document

... diuretics, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/direct renin inhibitors, NSAIDs and metformin; experiencing an intercurrent illness; or undergoing a ... See full document

... of angiotensin-converting enzyme (ACE) are partly under genetic control [1]; circulating lev- els of ACE are correlated with an insertion (I) / deletion (D) polymorphism [2]: DD genotypes have ... See full document

... all patients with venous thrombosis ...consecutive patients of less than 70 years of age with a first episode of objectively confirmed DVT ...of patients in the study group and ...these ... See full document

... The observed genotypes in the control population did not deviate significantly from the Hardy-Weinberg equilib- rium (p = 0.98). With regard to the genotype and allele distributions, no significant differences between ... See full document

... 23. Dulin BR, Krum H. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence. Curr Opin Cardiol 2006; 21: 393-99. 24. Ahmed A, Kiefe CI, Allman RM, Sims RV, DeLong JF. Survival ... See full document